Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation

Retinoic acid (RA) can induce growth arrest and neuronal differentiation of neuroblastoma cells and has been used in clinic for treatment of neuroblastoma. It has been reported that RA induces the expression of several HOXD genes in human neuroblastoma cell lines, but their roles in RA action are largely unknown. The HOXD cluster contains nine genes (HOXD1, HOXD3, HOXD4, and HOXD8-13) that are positioned sequentially from 3′ to 5′, with HOXD1 at the 3′ end and HOXD13 the 5′ end. Here we show that all HOXD genes are induced by RA in the human neuroblastoma BE(2)-C cells, with the genes located at the 3′ end being activated generally earlier than those positioned more 5′ within the cluster. Individual induction of HOXD8, HOXD9, HOXD10 or HOXD12 is sufficient to induce both growth arrest and neuronal differentiation, which is associated with downregulation of cell cycle-promoting genes and upregulation of neuronal differentiation genes. However, induction of other HOXD genes either has no effect (HOXD1) or has partial effects (HOXD3, HOXD4, HOXD11 and HOXD13) on BE(2)-C cell proliferation or differentiation. We further show that knockdown of HOXD8 expression, but not that of HOXD9 expression, significantly inhibits the differentiation-inducing activity of RA. HOXD8 directly activates the transcription of HOXC9, a key effector of RA action in neuroblastoma cells. These findings highlight the distinct functions of HOXD genes in RA induction of neuroblastoma cell differentiation.

[1]  C. Thiele,et al.  p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS–KCNR human neuroblastoma cell line , 1998, Oncogene.

[2]  B. Barrell,et al.  Maintenance of functional equivalence during paralogous Hox gene evolution , 2022 .

[3]  Stephen J. Elledge,et al.  Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.

[4]  X. Morin,et al.  Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. , 1997, Development.

[5]  R. Krumlauf,et al.  Retinoids and Hox genes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  M. Tomita,et al.  Position‐specific expression of Hox genes along the gastrointestinal tract , 2004, Congenital anomalies.

[7]  P. Hall,et al.  Ki67—Structure, function, and new antibodies , 1992, The Journal of pathology.

[8]  P. Kaldis,et al.  Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms , 2009, Oncogene.

[9]  Saraswati Sukumar,et al.  The Hox genes and their roles in oncogenesis , 2010, Nature Reviews Cancer.

[10]  R. Ross,et al.  Human neuroblastoma I-type cells are malignant neural crest stem cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[11]  K. Mechtler,et al.  Epigenetic Temporal Control of Mouse Hox Genes in Vivo , 2009 .

[12]  H. Ding,et al.  Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner* , 2006, Journal of Biological Chemistry.

[13]  N. Sidell,et al.  Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. , 1982, Journal of the National Cancer Institute.

[14]  Peter A. Lawrence,et al.  Homeobox genes: Their function in Drosophila segmentation and pattern formation , 1994, Cell.

[15]  R. Krumlauf,et al.  Hox genes and segmentation of the hindbrain and axial skeleton. , 2009, Annual review of cell and developmental biology.

[16]  H. B. Marsden,et al.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.

[17]  J. Maris Recent advances in neuroblastoma. , 2010, The New England journal of medicine.

[18]  K. Matsumoto,et al.  Retinoic acid negatively regulates p34cdc2 expression during human neuroblastoma differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  S L Cohn,et al.  Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[20]  S. Cohn,et al.  Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Brodeur Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[22]  H. Ding,et al.  MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. , 2009, The American journal of pathology.

[23]  T. Lufkin,et al.  Transcriptional control of Hox genes in the vertebrate nervous system. , 1996, Current opinion in genetics & development.

[24]  B. Wiedenmann,et al.  Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons , 1995, Mechanisms of Development.

[25]  A. Simeone,et al.  Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells , 1990, Nature.

[26]  B. McCarthy,et al.  HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma. , 2011, Cancer research.

[27]  S. Potter,et al.  Functional comparison of the Hoxa 4, Hoxa 10, and Hoxa 11 homeoboxes. , 2002, Developmental biology.

[28]  Hiroyuki Shimada,et al.  Morphologic features of neuroblastoma (Schwannian stroma‐poor tumors) in clinically favorable and unfavorable groups , 2002, Cancer.

[29]  H. B. Marsden,et al.  Histologic patterns of neuroblastoma related to prognosis and clinical staging , 1974, Cancer.

[30]  M. D'Esposito,et al.  Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells , 1991, Mechanisms of Development.

[31]  J. Beckwith,et al.  Observations on the histopathology of neuroblastomas. , 1968, Journal of pediatric surgery.

[32]  M. D'Esposito,et al.  Expression of HOX homeogenes in human neuroblastoma cell culture lines. , 1990, Differentiation; research in biological diversity.

[33]  Daniel Chourrout,et al.  Genome Regulation by Polycomb and Trithorax Proteins , 2007, Cell.

[34]  T. Svingen,et al.  Hox transcription factors and their elusive mammalian gene targets , 2006, Heredity.

[35]  K K Matthay,et al.  Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .

[36]  A. Simeone,et al.  HOX gene activation by retinoic acid. , 1991, Trends in genetics : TIG.

[37]  Joseph C. Pearson,et al.  Modulating Hox gene functions during animal body patterning , 2005, Nature Reviews Genetics.

[38]  Barbara Hero,et al.  The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  A. Simeone,et al.  Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. , 1988, Differentiation; research in biological diversity.

[40]  L. Selleri,et al.  Hox cofactors in vertebrate development. , 2006, Developmental biology.

[41]  A. Murray,et al.  Recycling the Cell Cycle Cyclins Revisited , 2004, Cell.

[42]  Denis Duboule,et al.  The rise and fall of Hox gene clusters , 2007, Development.

[43]  K. Matthay,et al.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  K. Matthay,et al.  Retinoid therapy of high-risk neuroblastoma. , 2003, Cancer letters.

[45]  M. Capecchi,et al.  Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5 , 1991, Nature.

[46]  Todd R Golub,et al.  Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation , 2008, Proceedings of the National Academy of Sciences.

[47]  M. Furtado,et al.  Hox gene expression in differentiating human neuroblastoma cells. , 1993, Biochemistry and molecular biology international.

[48]  M. Maden Retinoic acid in the development, regeneration and maintenance of the nervous system , 2007, Nature Reviews Neuroscience.

[49]  M. McBurney,et al.  Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line , 1982, Nature.

[50]  M. McBurney,et al.  Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells , 1982, The Journal of cell biology.